Are you Dr. Subramanian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
575 Beech St
1st Floor
Holyoke, MA 01040Phone+1 413-534-2870
Summary
- Dr. Hariharan Subramanian, MD is a cardiologist in Holyoke, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Connecticut, and Pennsylvania. He is affiliated with Holyoke Medical Center and Baystate Medical Center.
Education & Training
- Drexel University College of Medicine/Hahnemann University HospitalFellowship, Cardiovascular Disease, 2011 - 2014
- Abington Memorial HospitalResidency, Internal Medicine, 2004 - 2007
- Kilpauk Medical CollegeClass of 2000
Certifications & Licensure
- MA State Medical License 2014 - 2025
- PA State Medical License 2004 - 2014
- CT State Medical License 2008 - 2012
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 4 citationsNa+/H+ Exchanger Regulatory Factor 1 Mediates the Pathogenesis of Airway Inflammation in a Murine Model of House Dust Mite-Induced Asthma.Ananth K. Kammala, Devika Bahal, Canchai Yang, Reynold A. Panettieri, Rupali Das
Journal of Immunology. 2021-05-05 - 101 citationsEvidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients.Ali Daneshkhah, Vasundhara Agrawal, Adam Eshein, Hariharan Subramanian, Hemant K. Roy
Aging Clinical and Experimental Research. 2020-09-02 - 44 citationsOsthole, a Natural Plant Derivative Inhibits MRGPRX2 Induced Mast Cell Responses.Brianna N Callahan, Ananth K. Kammala, Meesum Syed, Canchai Yang, Christopher J. Occhiuto
Frontiers in Immunology. 2020-04-24
Press Mentions
- Invariant Natural Killer T Cells in Hematopoietic Stem Cell Transplantation: Killer Choice for Natural SuppressionFebruary 15th, 2020
Professional Memberships
- Member